Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.